NSD1 and laryngeal squamous cell carcinoma: Although not yet applied in clinical practice, recent studies have shown that disrupting mutations in NSD1 and NSD2 (Nuclear Receptor Binding SET Domain Proteins 1 and 2) define a group of good prognoses within laryngeal squamous cell carcinoma (LSCC) cases, but not in other HN subsites [9,10].